BridgeMD
New treatment option for Schizoaffective Disorder
Official title Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
ClinicalTrials.gov ID: NCT07058389
What this study is testing
- What it's testing
- Physical activity appears to be a novel and original adjunctive therapeutic approach in the management of patients with schizophrenia. It may help reduce schizophrenic symptoms, act as a pro-cognitive therapy, improve quality of life, and reduce cardiovascular comorbidities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Patients with schizophrenia, aged 18 to 55 years
- Having persistent negative symptoms (SNS), negative symptoms self-assessment scale \> 7
- Regularly monitored in the psychiatry department.
- Have no medical contraindications to physical activity
- Subject affiliated with or entitled to a social security system.
You likely can't join if
- Patient unsuitable for study in the opinion of the investigator
- Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
- Any subject presenting chronic or central neurological pathologies.
- Any subject deprived of liberty or subject to legal protection
- Excessive consumption of alcohol (\> 14 glasses per week) or caffeinated drinks (\> 400 mg of coffee per day).
- Pregnant women.
See the full eligibility criteria
- Patients with schizophrenia, aged 18 to 55 years
- Having persistent negative symptoms (SNS), negative symptoms self-assessment scale \> 7
- Regularly monitored in the psychiatry department.
- Have no medical contraindications to physical activity
- Subject affiliated with or entitled to a social security system.
- Subject having received informed information about the study and having co-signed, with the investigator, consent to participate in the study.
- Male or female.
- Patient unsuitable for study in the opinion of the investigator
- Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
- Any subject presenting chronic or central neurological pathologies.
- Any subject deprived of liberty or subject to legal protection
- Excessive consumption of alcohol (\> 14 glasses per week) or caffeinated drinks (\> 400 mg of coffee per day).
- Pregnant women.
- Subject unable to understand the purpose and conditions of the study, unable to give consent.
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Etienne, France, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Etienne, France, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.